Skip to Main Content

GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight

Conditions

Mental Health & Behavioral Research | Obesity & Weight Control

Phase I-II

What is the purpose of this trial?

If you are between 18 and 55 years of age and are overweight or have obesity you may qualify for a clinical trial evaluating a once weekly medication which may help with weight loss. The SEMA trial is funded by the National Institutes of Health (NIH) and the study medication (semaglutide vs. placebo) is provided at no cost to qualifying participants. Participants with diabetes are not eligible for this study.

  • Trial with
    National Institute of Diabetes and Digestive & Kidney Diseases (NIDDKD)
  • Start Date
    06/24/2020
  • End Date
    05/30/2021
Trial Image

For more information about this study, contact:

Rachel Hart

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    01/07/2021
  • Study HIC
    #2000027868